Bone densitometry firm Hologic enjoyed a strong fiscal 1996 thanksto higher sales of its Acclaim series of dual-energy x-ray bonedensitometers. The Waltham, MA, company's acquisition of miniC-arm manufacturer FluoroScan Imaging Systems also contributedto
Bone densitometry firm Hologic enjoyed a strong fiscal 1996 thanksto higher sales of its Acclaim series of dual-energy x-ray bonedensitometers. The Waltham, MA, company's acquisition of miniC-arm manufacturer FluoroScan Imaging Systems also contributedto Hologic's revenue growth.
For the year (end-September), Hologic posted revenues of $91.6million, up 62% compared with sales of $56.5 million in fiscal1995. The company's net income for the year stood at $11.4 million,compared with $3.3 million the year before, when a legal battlewith Lunar squeezed Hologic's profits.
For the fourth quarter, Hologic had revenues of $24.4 million,up 46% compared with sales of $16.7 million in the fourth quarterof 1995. The company's net income was $2.1 million, compared with$988,000 in the same period a year ago.
While the FluoroScan acquisition added over $3 million in salesto Hologic's fourth quarter, most of the company's growth camethrough sales in the bone densitometry segment: Hologic's revenuein the period would have grown 64% without the FluoroScan acquisition.Sales of Acclaim systems reached record levels in the U.S. dueto new drugs for treating osteoporosis, according to Hologic chairmanand CEO David Ellenbogen.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.